Results 41 to 50 of about 9,130,139 (414)
Confidential genetic testing and electronic health records: A survey of current practices among Huntington disease testing centers [PDF]
, 2020 BACKGROUND: Clinical care teams providing presymptomatic genetic testing often employ advanced confidentiality practices for documentation and result storage.
Barton, Stacey K +5 more
core +2 more sources
Chinese Medical Journal, 2015 Objective: The objective was to review the major differences of Huntington disease (HD) in Asian population from those in the Caucasian population. Data Sources: Data cited in this review were obtained from PubMed database and China National Knowledge ...
Miao Xu, Zhi-Ying Wu
doaj +1 more source
Mission Imputable: Correcting for Berkson Error When Imputing a Censored Covariate [PDF]
arXiv, 2023 To select outcomes for clinical trials testing experimental therapies for Huntington disease, a fatal neurodegenerative disorder, analysts model how potential outcomes change over time. Yet, subjects with Huntington disease are often observed at different levels of disease progression. To account for these differences, analysts include time to clinical
arxiv
The use of olanzapine in Huntington disease accompanied by psychotic symptoms [PDF]
, 2014 Huntington's disease is an autosomal dominant neurodegenerative disease. The disease begins between the ages of 30-50, including motor symptoms, psychiatric symptoms and is characterized by progressive dementia. Common psychiatric disorders of Huntington’
Cafer Alhan +4 more
core +1 more source
High Dose Sugammadex Administiration in a Case of Huntington Chorea
Medicine Science, 2016 Huntington Chorea is central nervues system disease that is inherited autosomal dominantly which causes miscellaneous difficulties and has features by the aspect of anesthesia management.
Mehmet Selcuk Uluer +3 more
doaj +1 more source
A Critical Review of White Matter Changes in Huntington’s Disease
Movement Disorders, 2020 Huntington’s disease is a genetic neurodegenerative disorder. White matter alterations have recently been identified as a relevant pathophysiological feature of Huntington’s disease, but their etiology and role in disease pathogenesis and progression ...
C. Casella +4 more
semanticscholar +1 more source
Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease [PDF]
, 2015 ACKNOWLEDGEMENTS We thank the PREDICT-HD sites, the study participants, the National Research Roster for Huntington Disease Patients and Families, the Huntington’s Disease Society of America and the Huntington Study Group.
Downing, Nancy +7 more
core +1 more source
Huntington’s disease: Neuropsychiatric manifestations of Huntington’s disease [PDF]
Australasian Psychiatry, 2018 Objectives: Huntington’s disease (HD) is a profoundly incapacitating, and ultimately fatal, neurodegenerative disease. HD is presently incurable, so the current goal is to allow affected individuals to live as well as possible with the illness, to maximise functional independence and quality of life for the person with HD, their carers and family ...
Anita MY Goh +5 more
openaire +4 more sources
Huntington’s Disease Clinical Trials Corner: April 2020
Journal of Huntington's Disease, 2020 In this edition of the Huntington’s Disease Clinical Trials Corner we expand on the UniQure AMT-130 and on the Neurocrine Biosciences KINECT-HD trials, and list all currently registered and ongoing clinical trials in Huntington’s disease.
F. B. Rodrigues, E. Wild
semanticscholar +1 more source
Biomarkers for Huntington's disease: an update [PDF]
, 2012 Huntington's disease (HD) is a devastating autosomal-dominant neurodegenerative condition caused by a CAG repeat expansion in the gene encoding huntingtin which is characterised by progressive motor impairment, cognitive decline and neuropsychiatric ...
Scahill, RI, Tabrizi, SJ, Wild, EJ
core +1 more source